We were always taught you can’t make a hostile bid for a private company, but that has not stopped MAGA mega-billionaire Elon Musk from an unprecedented $97.4 billion bid to acquire OpenAI’s nonprofit arm. As Bloomberg’s Matt Levine notes, “nonprofits do not get hostile takeover offers, and surely nonprofit boards do not have an obligation to maximize their valuation?”
It appears to be a longshot move to perhaps troll AI nemesis Sam Altman. The Information’s Rocket Drew and Stephanie Palazzolo point out that “any of OpenAI’s board directors could take matters into their own hands,” citing a California corporate law that allows an individual nonprofit director to sue to block a deal if they believe it compromises the organization’s mission. Liz Hoffman writes that maybe all this jousting shows that the U.S. remains the clear leader in AI.
With both proxy and Oscar season in full swing, Paul Singer seems to have taken a page out of There Will Be Blood this week, channeling Daniel Day-Lewis’ ethos: “I’m an oil man.” Elliott unveiled major new stakes at oil giants BP and Phillips 66, pushing for strategic changes, potential asset sales and a pullback in renewable energy investments. Singer’s firm was the busiest activist of 2024, and already looks poised to retain that title, unveiling four new billion-plus stakes since January 1st, including at Honeywell and Smiths Group.
Paul Weiss highlighted the latest trends in the shareholder activism landscape in a recent memo, including private equity firms increasingly “piggy-backing” off activist theses, an uptick in hostile M&A and greater focus on succession planning.
Meanwhile, the SEC is turning heads in a lot of ways. Acting Chairman Mark Uyeda announced that the commission is taking steps to reverse the proposed rule mandating companies disclose their Scope 3 emissions. He has made a series of moves that for the most part have cheered corporates, such as not allowing a flood of shareholder proposals on company proxies. However, the idea that investors could no longer use 13G filings to vote on things like staggered boards and poison pills surprised the institutional investor community.
Speaking of M&A, activism and New Orleans, please fill out our short survey ahead of the Tulane Corporate Law Institute conference only a few weeks away!
Have a great weekend,
GPP
|